seed
Stage
1
Investors
About
Lento Bio develops small-molecule topical eye-drop therapeutics designed to repair molecular damage in the aging crystalline lens to restore near vision caused by presbyopia and potentially prevent cataracts.
Explore Lento Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.